Holen Sie sich die Stockscreener-App
1.21
0.00%
0.00
Handel nachbörslich:
1.23
0.02
+1.65%
Schlusskurs vom Vortag:
$1.21
Offen:
$1.2
24-Stunden-Volumen:
528.89K
Relative Volume:
0.46
Marktkapitalisierung:
$166.05M
Einnahmen:
$4.35M
Nettoeinkommen (Verlust:
$-45.53M
KGV:
-1.1204
EPS:
-1.08
Netto-Cashflow:
$-44.79M
1W Leistung:
-3.97%
1M Leistung:
+16.35%
6M Leistung:
-5.84%
1J Leistung:
+31.45%
1-Tages-Spanne:
$1.19
$1.23
1-Wochen-Bereich:
$1.19
$1.28
52-Wochen-Spanne:
$0.7501
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Firmenname
Lucid Diagnostics Inc
Sektor
Branche
Telefon
212 949 4319
Adresse
360 MADISON AVENUE, NEW YORK
Vergleichen Sie LUCD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.21 | 158.08M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-11-08 | Eingeleitet | BTIG Research | Buy |
| 2021-11-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Eingeleitet | Needham | Buy |
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
Ranking Lucid Diagnostics Inc. among high performing stocks via toolsTreasury Yields & Real-Time Stock Entry Alerts - newser.com
Can Lucid Diagnostics Inc. stock sustain revenue growth2025 Earnings Impact & Technical Entry and Exit Tips - newser.com
Is Lucid Diagnostics Inc. stock oversold or undervaluedBull Run & Low Drawdown Trading Strategies - newser.com
Live market analysis of Lucid Diagnostics Inc.2025 Geopolitical Influence & Proven Capital Preservation Methods - newser.com
Is Lucid Diagnostics Inc. stock ready for a breakout2025 Trading Volume Trends & Daily Growth Stock Tips - newser.com
Is Lucid Diagnostics Inc. meeting your algorithmic filter criteriaQuarterly Portfolio Summary & Daily Chart Pattern Signals - newser.com
How Lucid Diagnostics Inc. stock reacts to oil pricesWall Street Watch & Verified Momentum Stock Watchlist - newser.com
Is Lucid Diagnostics Inc. stock supported by innovation pipelineJuly 2025 WrapUp & Weekly Watchlist of Top Performers - newser.com
Measuring Lucid Diagnostics Inc.’s beta against major indicesJuly 2025 Outlook & AI Optimized Trade Strategies - newser.com
Will Lucid Diagnostics Inc. stock maintain momentum in 2025Earnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com
Combining machine learning predictions for Lucid Diagnostics Inc.Weekly Trade Analysis & Verified Trade Idea Suggestions - newser.com
Will Lucid Diagnostics Inc. stock continue dividend increasesRate Cut & Fast Exit and Entry Trade Guides - newser.com
Why retail investors favor Lucid Diagnostics Inc. stockBuy Signal & Low Drawdown Trading Strategies - newser.com
Lucid Diagnostics Inc. (LUCD) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 - Eastern Progress
PAVmed (NASDAQ: PAVM) schedules Nov 13 webcast at 8:30 AM ET on third-quarter results - Stock Titan
Lucid Diagnostics Inc. (LUCD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Can Lucid Diagnostics Inc. stock surprise with earnings upsideJuly 2025 Setups & Risk Controlled Swing Trade Alerts - fcp.pa.gov.br
Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):